Newsletter Signup | Join Community | Cancer Types
Treatment of Stages I - IIA Hodgkins Lymphoma
Connect with Others at Top Cancer Centers - Second Opinion Options...
The precision cancer medicine Adcetris is changing the way recurrent Hodgkin lymphoma is managed.
Stay Current With Hodgkin Lymphoma Treatment Advances & Connect with Others
Adcetris precision cancer medicine chemotherapy combo highly effective treatment of Hodgkin lymphoma
Treatment of stage IIB of Hodgkin lymphoma
Increasing the intensity of chemotherapy requiring bone marrow transplant support is demonstrated to cure more patients
Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors
Cancers that begin in cells of the lymph system are referred to as malignant lymphomas
Neulasta® Safe and Effective for Hodgkin’s Patients Treated with ABVD Chemotherapy
It’s Not Just a Little Fever: Preventing Infection during Therapy for Lymphoma
Our understanding of lymphomas has allowed scientists to find new and unique ways of treating this blood cancer.
Rituxan Active in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma
Among women who are diagnosed with lymphoma during pregnancy, the outcomes for both mother and baby are often good
More Radiation Therapy Is Not Better for Elderly Patients with Hodgkin’s Lymphoma
Chemotherapy Alone Effective for Hodgkin’s Lymphoma.
With advances in personalized medicine, the look and feel of cancer treatment may change dramatically.
Similar Overall Survival with ABVD and BEACOPP for Advanced Hodgkin’s Lymphoma.
Adcetris Approved for Two Types of Lymphoma
Radiation Therapy Improves 10-Year Survival for Patients With Early Hodgkin’s Lymphoma
Children with Favorable-Risk Hodgkin’s Lymphoma May Benefit from Limited Radiation Therapy
Patients with Hodgkin’s Lymphoma at Risk for Heart Attack Later in Life.
Limited Therapy May Cure a Significant Fraction of Pediatric Patients with Early-Stage Hodgkin Lymphoma.
Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma
Reduced Intensity Transplants Show Promise for Hodgkin’s Lymphoma
Panobinostat Promising in Relapsed/Refractory Hodgkin’s Lymphoma
ABVD superior to MEC or Stanford V as HD Treatment
Some Children with Hodgkin’s Disease Can Skip Radiation Therapy
PET/CT Changes Staging and Treatment of Early Lymphoma
ABVD compared to MOPP-EBV-CAD and Standford V regimen in Hodkin's
Increase in Hodgkin’s Lymphoma in HAART Era
Beta 2-Microglobulin May Help Predict Survival in Early-Stage Hodgkin’s
Study Addresses Treatment of Older Hodgkin’s Patients
PET Scans More Effective Than CT in Lymphomas
Chemotherapy plus Radiation Recommended as Standard of Care in Early Hodgkin’s
Family History Associated with Increased Risk of Non-Hodgkin’s and Hodgkin’s Lymphoma
Chemotherapy Regimen ABVD Should be Considered Standard Initial Treatment for Advanced Hodgkin’s
Cardiac Complications Common among Patients who Received Radiation to the Chest for Hodgkin’s Disease
Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas
Smoking May Increase Risk of Hodgkin’s Lymphoma